News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wesche Holger
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/01/2022 |
4
| Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $5.03, valued at
$679.1k
|
|
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 9,000 shares
@ $16.1897, valued at
$145.7k
Sold 1,000 shares
@ $17.0299, valued at
$17k
Exercised 10,000 options to buy
@ $0.6, valued at
$6k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2020 |
4
| Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 1,400 shares
@ $14.0857, valued at
$19.7k
Exercised 1,400 options to buy
@ $0.6, valued at
$840 |
|
| 05/11/2020 |
4
| Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 5,350 shares
@ $14.1263, valued at
$75.6k
Sold 1,000 shares
@ $14, valued at
$14k
Sold 1,000 shares
@ $14.0651, valued at
$14.1k
Exercised 5,350 options to buy
@ $0.6, valued at
$3.2k
Exercised 1,000 options to buy
@ $0.6, valued at
$600
Exercised 1,000 options to buy
@ $0.6, valued at
$600 |
|
| 04/30/2020 |
4
| Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 1,250 shares
@ $14.052, valued at
$17.6k
Exercised 1,250 options to buy
@ $0.6, valued at
$750 |
|
| 02/04/2020 |
4
| Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 52,313 options to buy
@ $13.29, valued at
$695.2k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2019 |
3
| Wesche Holger (Chief Scientific Officer) has filed a Form 3 on Harpoon Therapeutics, Inc. |
|
|